Heart involvement in systemic sclerosis;La cardiopatia sclerodermica

Recenti Progressi in Medicina

Volumn 87, Issue 11, 1996, Pages 557-563

  Valentini, Gabriele ^a,c   Maione, Stefania ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NONE   (Italy)

Author keywords

Heart disease; Myocardial fibrosis; Scleroderma; Systemic sclerosis

Indexed keywords

CARDIOMYOPATHY; HUMAN; PATHOPHYSIOLOGY; REVIEW; SYSTEMIC SCLEROSIS;

CARDIOMYOPATHIES; HUMANS; SCLERODERMA, SYSTEMIC;

EID: 0030278293     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. th ed. Philadelphia: Saunders 1996; 1483-8.
2. Weiss S, Stead EA Jr, Warren JV, Bailey OT. Scleroderma heart disease with a consideration of certain visceral manifestations of scleroderma. Arch Intern Med 1943; 71: 749-6.
3. Oram S, Stokes W. The heart in scleroderma. Br Heart J 1961; 23: 243-59.
4. Sackner MA, Argun N, Kimbel P. The pathophysiology of scleroderma involving the heart and the respiratory system. Ann Intern Med 1964; 60: 611-30.
5. Bulkley BH, Ridolfi RL, Salyer WL, Hutchkins GM. Myocardial lesions of progressive systemic sclerosis: a cause of cardiac dysfunction. Circulation 1976; 53: 483-90.
6. Follansbee WP. The cardiovascular manifestations of systemic sclerosis (Scleroderma). Curr Probl Cardiol 1986; 11: 241-98.
7. D'Angelo WA, Fries J, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). Am J Med 1969; 46: 428-40.
8. Maione S, Valentini G, Giunta A, et al. Evaluation of cardiac structures and function in systemic sclerosis by Doppler echocardiography. Cardiology 1991; 79: 165-71.
9. McWhorter JE, LeRoy EC. Pericardial disease in scleroderma (systemic sclerosis). Am J Med 1974; 57: 566-75
10. Follansbee WP, Miller TR, Curtiss EJ, et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990; 17: 656-62.
11. Bulkley BH, Hutchins GM. Myocardial consequences of coronary artery bypass graft surgery. The paradox of necrosis in areas of revascularization. Circulation 1977; 56: 906-13.
12. James TN. De subitaneis mortibus: coronary arteries and conduotion system in scleroderma heart disease. Circulation 1974; 50: 844-56.
13. Janoslk DL, Osborn TG, Moore TL, Shah DG, Kenney RG, Zuckner J. Heart disease in Systemic Sclerosis. Sem Arthritis Rheum 1989; 19: 191-200.
14. Alexander EL, Firestein GS, Weiss JL et al. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis. Ann Intern Med 1986; 105: 661-8.
15. Ellis WN, Baer AN, Robertson RM, Pinens T, Kronenberg MW. Left ventricular dysfunction induced by cold exposure in patients with Systemic Sclerosis. Am J Med 1986; 80: 385-92.
16. Kahan A, Devaux JY, Amor B, et al. Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis. N Engl J Med 1986; 314: 1397-402.
17. Kahan A, Devaux JY, Amor B, et al. Pharmacodynamic effect of dipirydamole on thallium-201 myocardial perfusion in progressive sistemic sclerosis with diffuse scleroderma. Ann Rheum Dis 1986; 45: 718-25.
18. LeRoy EC. The heart in sytemic sclerosis. N Engl J Med 1984; 310: 188-9.
19. Kahan A, Nitenberg A, Foult JM, et al. Decreased coronary reserve in primary scleroderma myocardial disease. Arthritis Rheum 1985; 28: 637-46.
20. Thurm CA, Wigley FM, Dole WP, Wise RA. Failure of vasodilator infusion to alter pulmonary diffusing capacity in systemic sclerosis. Am J Med 1991; 90:547-52.
21. Valentini G, Leonardo G, Moles DA, et al. Transcutanecus oxygen pressure in systemic sclerosis. Evaluation at different sensor temperatures and relationship with skin blood flow. Arch Dermatol Res 1991; 283: 285-90.
22. Follansbee WP, Curtiss EJ, Medsger TA, et al. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 1984; 310: 142-8.
23. Follansbee WP, Curtiss EJ, Medsger TA Jr, Owens GR, Steen VD, Rodnan GP. Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma. Am J Med 1984; 77: 489-96.
24. Smith JV, Clements PJ, Levismann J, Furst D, Ross M. Echocardiographic features of progressive systemic sclerosis (PSS). Correlation with hemodynamic and postmortem studies. Am J Med 1979; 66: 28-33.
25. Clements PJ, Furst DE, Chabeen W, Tashkin D, Paulus HE, Roberts N. The relationship of arrythmias and conduction abnormalities to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS). Am J Med 1981; 71: 38-46.
26. Ferri C, Bernini L, Bongiorni MG, et al. Non invasive evaluation of cardiac dysrhytmias and their relationship with multisystemic symptoms in progressive systemic sclerosis patients. Arthritis Rheum 1985; 28: 1259-66.
27. Kostis JB, Seibold JR, Turkevich DA, et al. Prognostic importance of cardiac arrytmias in systemic sclerosis. Am J Med 1988; 84: 1007-15
28. Tirri G, Valentini G. Dati non pubblicati.
29. Bulkley BH, Klacsmann PG, Hutohins GM. Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathalogic study of progressive systemic sclerosis. Am Heart J 1978; 95: 563-9.
30. Ridolfi RE, Bulkley BH, Hutohins GM. The cardiac conduction system in progressive systemic sclerosis: clinical and pathologic features of 35 patients. Am J Med 1976; 61: 361-6.
31. Roberts NK, Cabeen WR, Moss J, Clements PJ, Furst DE. The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis. Ann Intern Med 1981; 94: 38-40
32. Follansbee WP, Curtiss EJ. Rahko PS, et al. The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature. Am J Med 1985; 79: 183-92.
33. Pignone A, Matucci Cerinic M, Bacucci A, et al. I potenziali ventricolari tardivi nella sclerosi sistemica: un metodo non invasivo di studio dell'impegno cardiaco. Ann Ital Med Int 1994; 9: 141-5.
34. Valentini G, Vitale DF, Giunta A, et al. Diastolic abnormalities in systemic sclerosis, evidence for associated defective cardiac functional reserve. Ann Reum Dis 1996; in corso di stampa.
35. Anvari A, Graninger W, Schneider B, Sochor H, Weber H, Schmidinger H. Cardiac involvement in systemic sclerosis. Arthritis Rheum 1992; 35: 1356-61.
36. Medsger TA Jr, Masi AT, Rodnan GP, Benedek TK, Robinson H. Survival with systemic sclerosis (scleroderma): a life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971; 75: 369-76.
37. Clements PJ, Lachenbruch PA, Furst DE, Paulus HE, Sterz MG. Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 1991; 34: 1371-80.
38. Siegel RJ, O'Connor B, Mena I, Criley JM. Left ventricular function at rest and during Raynaud's phenomenon in patients with scleroderma. Am Heart J 1984; 108: 1469-76.
39. th International Workshop on scleroderma research. Cambridge, July 14-16, 1996. Abstract 34.
40. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and reninangiotensin- aldosterone system. Circulation 1991; 83: 1849-65.